This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> CureVac (CVAC) upgraded to Buy from Neutral at UBS; tgt raised to $18
Downgrades:
> Cognizant Tech (CTSH) downgraded to Underperform from Market Perform at MoffettNathanson; tgt lowered to $60
> DXC Technology (DXC) downgraded to Underperform from Market Perform at MoffettNathanson; tgt lowered to $28
Others:
> Alpine Immune Sciences (ALPN) initiated with an Overweight at Morgan Stanley; tgt $17
> CF Industries (CF) initiated with an Overweight at Wells Fargo; tgt $110
> Corteva (CTVA) initiated with an Overweight at Wells Fargo; tgt $78
> FMC Corp (FMC) assumed with an Overweight at Wells Fargo; tgt $148
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
